- Home
- INAB vs LVTX Comparison
INAB vs LVTX Comparison
Compare INAB & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- LVTX
- Stock Information
- Founded
- INAB 2016
- LVTX 2016
- Country
- INAB United States
- LVTX Netherlands
- Employees
- INAB N/A
- LVTX N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- INAB Health Care
- LVTX Health Care
- Exchange
- INAB Nasdaq
- LVTX Nasdaq
- Market Cap
- INAB 24.0M
- LVTX 25.3M
- IPO Year
- INAB 2021
- LVTX 2021
- Fundamental
- Price
- INAB $0.24
- LVTX $0.99
- Analyst Decision
- INAB Strong Buy
- LVTX Buy
- Analyst Count
- INAB 3
- LVTX 3
- Target Price
- INAB $7.75
- LVTX $3.33
- AVG Volume (30 Days)
- INAB 750.7K
- LVTX 172.5K
- Earning Date
- INAB 11-12-2024
- LVTX 12-10-2024
- Dividend Yield
- INAB N/A
- LVTX N/A
- EPS Growth
- INAB N/A
- LVTX N/A
- EPS
- INAB N/A
- LVTX N/A
- Revenue
- INAB N/A
- LVTX $7,345,000.00
- Revenue This Year
- INAB N/A
- LVTX N/A
- Revenue Next Year
- INAB N/A
- LVTX N/A
- P/E Ratio
- INAB N/A
- LVTX N/A
- Revenue Growth
- INAB N/A
- LVTX N/A
- 52 Week Low
- INAB $0.22
- LVTX $0.96
- 52 Week High
- INAB $1.93
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- INAB 38.43
- LVTX 31.29
- Support Level
- INAB $0.23
- LVTX $0.96
- Resistance Level
- INAB $0.32
- LVTX $1.95
- Average True Range (ATR)
- INAB 0.03
- LVTX 0.13
- MACD
- INAB -0.01
- LVTX -0.05
- Stochastic Oscillator
- INAB 10.62
- LVTX 2.84
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.